The largest database of trusted experimental protocols

Bluo gal

Manufactured by Thermo Fisher Scientific
Sourced in United States

Bluo-Gal is a chromogenic substrate used for the detection and quantification of beta-galactosidase activity in biological samples. It is a colorless compound that undergoes hydrolysis in the presence of beta-galactosidase, resulting in the formation of a blue colored product. The intensity of the blue color is proportional to the level of beta-galactosidase activity, allowing for easy visual or spectrophotometric analysis.

Automatically generated - may contain errors

8 protocols using bluo gal

1

Comparative Cardiac Histology Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Embryonic, neonatal and adult miR1-TG and WT littermates were sacrificed and hearts were removed and processed for hematoxylin-eosin staining using standard techniques. For whole-mount Bluo-Gal staining, adult hearts were bisected, fixed overnight in formalin, and incubated with a solution containing 1 mg/mL halogenated indolyl-β-galactoside (Bluo-Gal, Invitrogen, Catalog No. 15519028) for 24 h at room temperature, followed with washing and fixation. To facilitate comparison between genotypes, WT and TG littermate hearts were processed and stained in parallel using the same staining solution for identical durations. Hearts were photographed under identical lighting conditions after clearing in 2:1 benzyl alcohol-benzyl benzoate (Sigma-Aldrich, Catalog No. 305197 and B6630, respectively).
+ Open protocol
+ Expand
2

Modular Assembly of PUF Constructs

Check if the same lab product or an alternative is used in the 5 most similar protocols
His-tagged PUF or 3xFlag-tagged TPUF constructs for E. coli or mammalian expression were assembled in pET28-GG-PUF or pCMV-TTP (C147R)-GG-PUF, respectively. Receiving vector of choice (50 ng) and 8 modules of choice (75 ng each) were combined with 1 μl T4 DNA ligase and 1 μl BsaI-HF in 10 μl 1× T4 DNA ligase buffer. The reactions were cycled 10 times for 5 min at 37°C and 10 min at 16°C, and a final incubation of 15 min at 37°C. TOP10 E. coli cells (Invitrogen) were then transformed with the cloning reactions and plated on LB plates (Cell Media Facility, UIUC) with either kan or amp selection, and supplemented with 10 μl 0.4 M IPTG (GoldBio) and 40 μl 20 mg/ml Bluo-Gal (Invitrogen) for blue-white screening. All the plasmids for E. coli expression were purified using Qiagen Qiaprep Spin Miniprep kit, and plasmids for mammalian expression were purified using Qiagen Plasmid Mini kit.
+ Open protocol
+ Expand
3

Quantifying Mutation Rates in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Control (0 MM) and mismatch (U/G MM)-containing plasmids (1.5 μg per well in 6-well plate) were transfected into breast cancer cells, extracted 48 hr later using the Wizard Plus SV Miniprep kit (Promega, A1460), and treated with DpnI (NEB, R0176) for 15 min at 37°C. Plasmids (5 ng) were electroporated into 20 μL MBM7070 competent cells. After transformation, the cells were recovered in S.O.C. medium (Invitrogen, 15544–034) for 1 hr at 37°C and plated on LB agar plates containing 100 μg/mL carbenicillin (Sigma-Aldrich, C1389), 1 mM IPTG (Invitrogen, 15529–019), and 0.03% (w/v) Bluo-Gal (Invitrogen, 15519–028). After incubation at 37°C overnight, the plates were stored at 4°C in the dark to allow color development. The percentage of white to total colonies (2,000–3,000) per sample was calculated as ‘mutation rate’. For mutation fate and trinucleotide context analysis shown in Figure 1D,E, we sequenced the reporter region (Figure 1A) of the pSP189-SnA shuttle vector in all white colonies (ACGT, Inc) using primer R250 (TTTTTGTGATGCTCGTCAGG) (Chen et al., 2014 (link)). Mutations were tabulated from the alignments between these sequences and the reference sequence of the starting reporter region.
+ Open protocol
+ Expand
4

Tissue Preparation and LacZ Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Under deep pentobarbital anesthesia, mice were perfused with PBS, followed by 2.2% formaldehyde and 0.2% glutaraldehyde in PBS. Brains were removed and fixed for 1 h in the same fixative at 4 °C and then soaked in 30% sucrose in 0.1 m phosphate buffer for 12 h at 4 °C. The brains were frozen in tissue-tek OCT compound and cut at 30 μm thickness. Sections were subjected to lacZ staining overnight at 37 °C. LacZ staining solution contains 0.5 mg ml−1 Bluo Gal (Invitrogen, Carlsbad, CA, USA), 3 mm K4Fe(CN)6, 3 mm K3Fe(CN)6 and 1 mm MgCl2 in PBS.
+ Open protocol
+ Expand
5

Two-Hybrid Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The two-hybrid assays were performed essentially as described previously (Möckli and Auerbach, 2004 (link)). Briefly, for each interaction pair and controls, several colonies were grown to an OD600 of 0.5–0.8. One absorbance unit of yeast cultures was pelleted, and cells were lysed, resuspended in 20 µl water, and then transferred to a transparent flat-bottom 96-well plate. 100 µl PXG buffer containing Bluo-gal (Invitrogen) was added, and the absorbance at 420 nm was measured with a flatbed scanner. Images were analyzed using ImageJ (National Institutes of Health).
+ Open protocol
+ Expand
6

Recombinant CUL2-VHL complex production

Check if the same lab product or an alternative is used in the 5 most similar protocols
WT and catalytically reduced CSN5H138A bacmids were a kind gift from Radoslav Enchev (The Francis Crick Institute, London)19 . pcDNA3-myc3-CUL2 was a gift from Yue Xiong (Addgene plasmid #1989235 (link)). HA-VHL wt-pBabe-puro was a gift from William Kaelin (Addgene plasmid #1923436 (link)). RBX1, ELOB and ELOC were cloned from cDNA from the Mammalian Gene Collection purchased from Dharmacon. To improve protein yield, an N-terminally truncated (1–53) natural isoform of VHL was also produced for use with MS. Both isoforms of VHL were subcloned into a pET-52b(+) vector (Novagen) to add an N-terminal Step-Tag II. Genes were assembled into pACEBac1 using I-CeuI/BstXI restriction sites via the MultiBac system37 (link). RBX1 and CUL2 were assembled into one vector and ELOB, Strep II-VHL(ΔN) and ELOC into a second vector. Correct assembly was confirmed by sequencing of entire genes. DH10EmBacY cells were transformed with each assembly and blue/white selection was performed on l-agar plates containing 50 μg ml−1 kanamycin, 7 μg ml−1 gentamycin, 10 μg ml−1 tetracyclin, 100 μg ml−1 Bluo-Gal (Thermo Scientific) and 40 mg ml−1 IPTG. DH10MultiBac bacmid DNA was isolated from single white colonies. Recombinant baculoviruses were generated in Sf9 insect cells (a clonal isolate from Sf21, Life Technologies #11496015) using standard amplification procedures.
+ Open protocol
+ Expand
7

Production and Purification of Recombinant sFlt-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sFlt sequence for the first 3 Ig-like extracellular domains of sFlt-1 was cloned as previously described [13 ] into the pFastBac1 plasmid (Life Technologies) and then transformed into DH10Bac E.coli, which were plated on triple antibiotic plates containing kanamycin (50 μg/mL, Sigma Aldrich), gentamicin (7 μg/mL, Sigma Aldrich), tetracycline (10 μg/mL, Sigma Aldrich), IPTG (40 μg/mL, Sigma Aldrich) and Bluo-gal (100 μg/mL, Thermo Fisher Scientific). The sFlt gene-containing bacmid was isolated from DH10Bac E.coli (Life Technologies) and transfected into SF9 insect cells for virus production (provided by the Tissue Culture Facility, UC Berkeley). Virus was then used to infect High Five insect cells (provided by the Tissue Culture Facility, UC Berkeley) to induce sFlt protein expression. After 3 days, protein was purified from the supernatant using Ni-NTA agarose beads (Qiagen Laboratories). Recombinant sFlt was eluted from the Ni-NTA beads using an imidazole (Sigma Aldrich) gradient and then concentrated and buffer exchanged with 10% glycerol/PBS using Amicon Ultra-15mL Centrifugal devices (EMD Millipore). The protein solution was sterile filtered and the concentration was determined by BCA assay (Thermo Fisher Scientific). The molecular weight of sFlt was determined from a 4–20% gradient SDS-PAGE gel and estimated to be 50 kDa [12 (link)].
+ Open protocol
+ Expand
8

Production and Purification of sFlt-1(3) Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sFlt-1 sequence for the first 3 lg-like extracellular domains of sFlt-1 (3) [15 (link)] was cloned into the pFastBac1 plasmid (Life Technologies) and then transformed into DH10Bac E.coli, which were plated on triple antibiotic plates containing kanamycin (50 μg/mL), gentamicin (7 μg/mL, Sigma Aldrich), tetracycline (10 μg/mL, Sigma Aldrich), IPTG (40 μg/mL, Sigma Aldrich) and Bluo-gal (100 μg/mL, Thermo Fisher Scientific). The sFlt-1 (3) gene-containing bacmid was isolated from DH10Bac E.coli (Life Technologies) and transfected into SF9 insect cells for virus production (provided by the Tissue Culture Facility, UC Berkeley). Virus was then used to infect High Five insect cells (provided by the Tissue Culture Facility, UC Berkeley) to induce sFlt-1 (3) protein expression. After 3 days, protein was purified from the supernatant using Ni-NTA agarose beads (Qiagen Laboratories). Recombinant sFlt-1(3) was eluted from the Ni-NTA beads using an imidazole gradient and then concentrated and buffer exchanged with 10% glycerol/PBS using Amicon Ultra-15mL Centrifugal devices (EMD Millipore). The protein solution was sterile filtered and the concentration was determined using a BCA assay (Thermo Fisher Scientific). The molecular weight of sFlt-1(3) was determined from a 4-20% gradient SDS-PAGE gel. For convenience, we refer to this protein as sFlt in this manuscript.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!